Therapeutic use of psilocybin: Practical considerations for dosing and administration
Jagpaul Kaur Deol, Caroline A. Maccallum, Lindsay A. Lo, Carly A. Pistawka
Frontiers in Psychiatry December 1, 2022 DOI: 10.3389/fpsyt.2022.1040217 via OpenAlex
Summary
AI-generated from the abstractInterest in psilocybin as a therapeutic approach has grown rapidly, yet health care professionals lack practical guidance on the topic, especially given the medical complexity and vulnerability of patients who may receive psilocybin-assisted psychotherapy. This article reviews basic psilocybin pharmacology and pharmacokinetics, indications, practical therapeutic strategies such as dosing, administration, and monitoring, and safety considerations including contraindications, adverse events, and drug interactions. The goal is to increase health care professionals' knowledge and comfort to discuss and counsel patients on psilocybin therapy, ultimately improving patient care and safety.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Psilocybin |
| Keywords | Dosing Health professionals Health care Adverse effect |
| Citations | 95 |
| Key finding | The article provides an overview of practical considerations for psilocybin therapy, including pharmacology, dosing, administration, monitoring, and safety, to help health care professionals counsel patients. |
Abstract
The interest in psilocybin as a therapeutic approach has grown exponentially in recent years. Despite increasing access, there remains a lack of practical guidance on the topic for health care professionals. This is particularly concerning given the medical complexity and vulnerable nature of patients for whom psilocybin-assisted psychotherapy may be considered. This article aims to provide health care professionals with an overview of practical considerations for psilocybin therapy, rooted in a patient safety focus. Within this piece we will review basic psilocybin pharmacology and pharmacokinetics, indications, practical therapeutic strategies (e.g., dosing, administration, monitoring) and safety considerations (e.g., contraindications, adverse events, and drug interactions). With this information, our goal is to increase the knowledge and comfort of health care professionals to discuss and counsel their patients on psilocybin therapy, ultimately improving patient care and safety.